RET-Positive Metastatic NSCLC
Playback speed
10 seconds
ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo in 1L mNSCLC: AE Management in POSEIDON Trial
By
ASCO 2022 Conference Coverage
FEATURING
Byoung Chul Cho
By
ASCO 2022 Conference Coverage
FEATURING
Byoung Chul Cho
59 views
June 23, 2022
Login to view comments.
Click here to Login